Cytora reviews

Cytora is currently failing. They're desperately searching for 'product-market fit' which is eluding them. As such, they are continually restructuring teams, hiring people to then make them redundant months later, and working key members of staff beyond their limit (resulting in one senior team member reduced to tears in the office due to exhaustion). Other key members have recognised this and left. Machine Learning features less and less in their product roadmap, in favour of simple automation tools sold to small insurance brokers, usually on a consultancy basis. Since series B funding in early 2019 they have made no new sales deals, and have in fact lost two of their biggest pipeline deals. How long before investors pull the plug? Management have no empathy, whilst selling the vision of Cytora being the next 'unicorn'. Growth plans are grossly inflated. Stock options are worthless, and subject to continual dilution.

- Current management do not know how to effectively grow the company - Management taking a shotgun approach to product development - 20% of the company were sacked in November 2019 without any justification